Loading...
Harmful Side Effects: How drug companies undermine global health
Pearce, Oliver Kamal-Yanni, Mohga
Pearce, Oliver
Kamal-Yanni, Mohga
Citations
Altmetric:
Titre
Publication date
2018-09-18
Document type
Briefing note
Pages
24
Author(s)
Advisors
Editor(s)
Other Contributors
Affiliation
ePub Date
Submitted date
Subject
Local subject classification
MeSH
Country
Collections
Files
Loading...
English paper
Adobe PDF, 1.45 MB
Description
<html>
<head>
<title></title>
</head>
<body>
<p>New Oxfam research shows that four pharmaceutical companies – Abbott, Johnson & Johnson, Merck and Pfizer – systematically hide their profits in overseas tax havens. They appear to deprive developing countries of more than $100m (around £80m) every year – money that is urgently needed to meet the health needs of people in these countries – while charging very high prices for their products. In the UK, these four companies may be underpaying around £125m of tax each year. These corporations also deploy massive lobbying operations to influence trade, tax and health policies in their favour and give their damaging behavior greater apparent legitimacy. Tax dodging, high prices and political influencing by pharmaceutical companies exacerbate the yawning gap between rich and poor, between men and women, and between advanced economies and developing ones.</p>
</body>
</html>
Language
English
Other Titles
Abstract
Citation
Publisher(s)
Journal
Journal Theme
Volume
Issue
Research Unit
Table of contents
Series
ISSN
EISSN
ISBN
978-1-78748-321-7